Alkeon Capital Management - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,084,000
-70.0%
224,945
-55.0%
0.00%
-66.7%
Q3 2021$3,615,000
-21.7%
500,0000.0%0.01%
-14.3%
Q2 2021$4,615,000
-25.0%
500,0000.0%0.01%
-22.2%
Q1 2021$6,155,000
-12.7%
500,0000.0%0.01%
-18.2%
Q4 2020$7,050,000
+193.8%
500,000
+150.0%
0.01%
+175.0%
Q3 2020$2,400,000
-27.7%
200,0000.0%0.00%
-50.0%
Q2 2020$3,320,000
+45.9%
200,0000.0%0.01%
-20.0%
Q1 2020$2,276,000
-7.6%
200,0000.0%0.01%
+11.1%
Q4 2019$2,464,000200,0000.01%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders